Literature DB >> 12676532

Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival.

Suzhen Chen1, Alain Mangé, Ling Dong, Sylvain Lehmann, Melitta Schachner.   

Abstract

Many uncertainties remain regarding the physiological function of the prion protein PrP and the consequences of its conversion into the pathological scrapie isoform in prion diseases. Here, we show for the first time that different signal transduction pathways are involved in neurite outgrowth and neuronal survival elicited by PrP in cell culture of primary neurons. These pathways include the nonreceptor Src-related family member p59(Fyn), PI3 kinase/Akt, cAMP-dependent protein kinase A, and MAP kinase. Regulation of Bcl-2 and Bax expression also correlates with the survival effect elicited by PrP. The combined results, along with our observation that PrP carries the recognition molecule-related HNK-1 carbohydrate, argue strongly for a role of the molecule in neural recognition by interacting with yet unknown heterophilic neuronal receptors, as shown by comparison of neurite outgrowth from neurons of PrP-deficient and wild-type mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676532     DOI: 10.1016/s1044-7431(02)00014-3

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  59 in total

Review 1.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

2.  Cellular prion protein promotes regeneration of adult muscle tissue.

Authors:  Roberto Stella; Maria Lina Massimino; Marco Sandri; M Catia Sorgato; Alessandro Bertoli
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

Review 3.  New molecular insights into cellular survival and stress responses: neuroprotective role of cellular prion protein (PrPC).

Authors:  Raymond Yen-Yu Lo; Woei-Cherng Shyu; Shinn-Zong Lin; Hsiao-Jung Wang; Shun-Sheng Chen; Hung Li
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

4.  Normal cellular prion protein is a ligand of selectins: binding requires Le(X) but is inhibited by sLe(X).

Authors:  Chaoyang Li; Poki Wong; Tao Pan; Fan Xiao; Shaoman Yin; Binggong Chang; Shin-Chung Kang; James Ironside; Man-Sun Sy
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

5.  Axonal prion protein is required for peripheral myelin maintenance.

Authors:  Juliane Bremer; Frank Baumann; Cinzia Tiberi; Carsten Wessig; Heike Fischer; Petra Schwarz; Andrew D Steele; Klaus V Toyka; Klaus-Armin Nave; Joachim Weis; Adriano Aguzzi
Journal:  Nat Neurosci       Date:  2010-01-24       Impact factor: 24.884

Review 6.  Is, indeed, the prion protein a Harlequin servant of "many" masters?

Authors:  M Catia Sorgato; Caterina Peggion; Alessandro Bertoli
Journal:  Prion       Date:  2009-10-04       Impact factor: 3.931

7.  The cellular form of the prion protein guides the differentiation of human embryonic stem cells into neuron-, oligodendrocyte-, and astrocyte-committed lineages.

Authors:  Young Jin Lee; Ilia V Baskakov
Journal:  Prion       Date:  2014-11-01       Impact factor: 3.931

8.  Prion protein regulates glutamate-dependent lactate transport of astrocytes.

Authors:  Ralf Kleene; Gabriele Loers; Julia Langer; Yveline Frobert; Friedrich Buck; Melitta Schachner
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 9.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

10.  The cellular prion protein interacts with the tissue non-specific alkaline phosphatase in membrane microdomains of bioaminergic neuronal cells.

Authors:  Myriam Ermonval; Anne Baudry; Florence Baychelier; Elodie Pradines; Mathéa Pietri; Kimimitsu Oda; Benoît Schneider; Sophie Mouillet-Richard; Jean-Marie Launay; Odile Kellermann
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.